Post-earnings recap
Reported
Thu, Feb 4, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Quest Diagnostics reported an EPS of $4.48, exceeding expectations, but the stock fell by 3.87% following the announcement. The lack of revenue details and guidance may have contributed to the negative stock reaction. Investors may be cautious due to the absence of additional insights from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.48 | N/A | +4.77% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.